Skip to content
by Legal Desire
7 October 2026

DLA Piper advises IntraBio on US$2.0 billion acquisition by Shionogi

Advising firms

Deal team

20 lawyers named
LawyerFirmSeniorityPracticeOffice
Josh Seidenfeld Lead DLA Piper Partner Corporate and Securities Northern California
Michael Patrone DLA Piper Partner Not stated Not stated
Philipp Tsukanov DLA Piper Partner Not stated Not stated
Rachel Myung DLA Piper Not stated Corporate Not stated
Matt Savoff DLA Piper Not stated Corporate Not stated
Kayleigh Nevin DLA Piper Not stated Corporate Not stated
Jason Parfet DLA Piper Not stated Corporate Not stated
Ali Pontious DLA Piper Not stated Corporate Not stated
Jason Veit DLA Piper Not stated Employee Benefits and Executive Compensation Not stated
Lauren Murdza DLA Piper Not stated Life Sciences Licensing Not stated
Arthur Cohn DLA Piper Not stated Life Sciences Licensing Not stated
Jae Kim DLA Piper Not stated FDA Not stated
Christine Lentz DLA Piper Not stated FDA Not stated
Victoria Lee DLA Piper Not stated Intellectual Property Not stated
Marco Berrios DLA Piper Not stated Intellectual Property Not stated
Georgia Jolink DLA Piper Not stated Labor and Employment Not stated
Jessica Jackson DLA Piper Not stated Labor and Employment Not stated
Neil Balmert DLA Piper Not stated Tax Not stated
Kevin England DLA Piper Not stated Tax Not stated
Nicholas Klein DLA Piper Not stated Global Trade and CFIUS Not stated

17 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 2bn (US$2 billion)
What the figure measures
Total transaction value
Client
IntraBio Inc.Sell-side
Counterparties
Shionogi Inc. (Buy-side)